Table 2 Comparison of mean time for accomplishing different tasks for a clinical trial startup phase before and after implementation of the intervention protocol
From: Streamlining and cycle time reduction of the startup phase of clinical trials
Before implementing the intervention | After implementing the intervention | P value | Percentage reduction | |
|---|---|---|---|---|
Mean [SD] (week) | Mean [SD] (week) | |||
PCLM approval | 1.7 [2.0] | 0.7 [0.94] | 0.59 | 60.4 |
IDS approval | 4.2 [3.6] | 1. 5 [2.7] | 0.27 | 64.9 |
IRB approval | 7.5 [3.1] | 6.6 [5.7] | 0.27 | 12 |
From confidentiality agreement to IRB approval | 24.8 [8.2] | 13.5 [11.6] | 0.36 | 45.6 |